Nasdaq vktx.
VKTX has move up from $4.00 a share to nearly $11.00 a share, largely in sympathy since those Madrigal trial results were announced. Therefore, I have taken profits on most of my small stake in VKTX.
Viking Therapeutics, Inc. (NASDAQ:VKTX) insiders who bought shares over the past year were rewarded handsomely last week. The stock rose 8.7%, resulting in a US$167m rise in the company's market ...Jul 10, 2023 · Below is Validea's guru fundamental report for VIKING THERAPEUTICS INC (VKTX). Of the 22 guru strategies we follow, VKTX rates highest using our Quantitative Momentum Investor model based on the ... hace 12 horas ... Join SI Premium – FREE. Viking Therapeutics (NASDAQ: VKTX) Climbs 13%. The reason for the spike wasn't clear but it may be tied to news Roche ...Source: Shutterstock. Viking Therapeutics (NASDAQ: VKTX) stock is on the move Wednesday as the clinical-stage biopharmaceutical company reveals data from a clinical trial. This data comes from its ...Viking Therapeutics, Inc. (NASDAQ:VKTX) shares were also up, gaining 42% to $12.92 after the company reported results from its Phase 1 trial of VK2735 for the potential treatment of various ...
Stock Ratings Screener · Free Ratings Newsletter. This page (NASDAQ:VKTX) was last updated on 12/4/2023 by ...SAN DIEGO, Oct. 5, 2021 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic ...
May 13, 2021 · So we'll take a look at whether insiders have been buying or selling shares in Viking Therapeutics, Inc. (NASDAQ:VKTX). ... NasdaqCM:VKTX Insider Trading Volume May 13th 2021.
MSFT. Microsoft Corporation Common Stock. $352.60 -0.20 -0.06%. Viking Therapeutics, Inc. Common Stock (VKTX) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading ... hace 2 días ... VKTXMercado de Valores Nasdaq • Precio de NLS en tiempo real • DIVISA EN USD • Biotechnology & Medical Research. Viking Therapeutics Inc (VKTX).Viking Therapeutics, Inc. (NASDAQ:VKTX) reported a wider loss of 19 cents per share for the first quarter compared to a loss of 13 cents per share a year ago. Analysts, on average, had estimated a ...Viking Therapeutics (NASDAQ: VKTX) has had a very promising 2023.They announced very good early results for an obesity drug in March. They then quickly used those good results to sell $250 million ...
Real time Viking Therapeutics (VKTX) stock price quote, stock graph, news & analysis.
SAN DIEGO, April 11, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for ...
Nov 30, 2023 · The latest price target for . Viking Therapeutics (NASDAQ: VKTX) was reported by Truist Securities on Monday, October 2, 2023.The analyst firm set a price target for 32.00 expecting VKTX to rise ... Strong Quarter-End Cash Position of $393M. SAN DIEGO, July 26, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX ), a clinical-stage biopharmaceutical company focused on the ...Viking Therapeutics (NASDAQ:VKTX) Lifted to Sell at StockNews.com marketbeat.com - August 24 at 1:17 AM: 5 Best Weight Loss Stocks To Invest In insidermonkey.com - August 22 at 5:54 PM: E Fund Management Co. Ltd. Invests $511,000 in Viking Therapeutics, Inc. (NASDAQ:VKTX) marketbeat.com - August 22 at 9:24 AMClinical-stage biotech Viking Therapeutics (NASDAQ:VKTX) added ~39% pre-market Tuesday after announcing that its obesity candidate VK2735 led to an average body weight reduction of up to ~8% in a ...Viking Therapeutics, Inc. Common Stock (VKTX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
Nasdaq Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. Data Link's cloud-based technology platform allows you to search, discover and access ...November 28, 2023. Technologies. In the last trading session, 1.46 million shares of the Viking Therapeutics Inc (NASDAQ:VKTX) were traded, and its beta was 0.61. Most recently the company’s share price was $12.00, and it changed around -$0.28 or -2.28% from the last close, which brings the market valuation of the company to $1.20B.Dec 4, 2023 · Viking Therapeutics Inc (NASDAQ:VKTX)’s Major holders. Insiders own 5.89% of the company shares, while shares held by institutions stand at 68.75% with a share float percentage of 73.05%. Investors are also buoyed by the number of investors in a company, with Viking Therapeutics Inc having a total of 246 institutions that hold shares in the ... SAN DIEGO, Oct. 17, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic ...Jan 24, 2022 · What happenedInvestors didn't exactly launch a raid on Viking Therapeutics (NASDAQ: VKTX) stock during Monday's trading session. The shares tumbled by nearly 7% on the back of discouraging news ...
VKTX Viking Therapeutics Options Ahead of Earnings Analyzing the options chain and the chart patterns of VKTX Viking Therapeutics prior to the earnings report this week, I would consider purchasing the 11usd strike price Calls with an expiration date of 2024-1-19, for a premium of approximately $1.80. Rhumbline Advisers acquired a new position in Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 127,829 shares of the biotechnology company’s stock, valued at approximately $2,072,000. Rhumbline …
Viking Therapeutics (NASDAQ:VKTX) is a great speculative biotech play to look into. The reason why I state that is because I believe it has huge potential as a long-term play.Nasdaq +78.81(+0.55%) Russell 2000 1,862.64 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Advertisement Viking Therapeutics, Inc. (VKTX) NasdaqCM - NasdaqCM Real... See more5 Best Weight Loss Stocks To Invest In Viking Therapeutics, Inc. (NASDAQ:VKTX) Q2 2023 Earnings Call Transcript 10 Stocks Wall Street Analysts and Billionaires Are Crazy About 15 Best-Performing ...Apr 16, 2023 · VIKING THERAPEUTICS INC ( VKTX) is a small-cap value stock in the Biotechnology & Drugs industry. The rating using this strategy is 94% based on the firm’s underlying fundamentals and the stock ... Viking Therapeutics (NASDAQ: VKTX) has had a very promising 2023. They announced very good early results for an obesity drug in March. They then quickly used those good results to sell $250 ...SAN DIEGO, Oct. 25, 2021 /PRNewswire/ -- Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX ), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic ...Viking Therapeutics (NASDAQ: VKTX) stock jumped 69% yesterday on news about Phase 1 testing of their weight loss treatment, VK2735. Given the excitement in the market more generally about the new existence of weight loss drugs that really, actually, work we might think this is great.
Clinical-stage biotechnology company Viking Therapeutics, Inc. (NASDAQ: VKTX) stock jumped more than 50% on positive Phase 1 data on its novel dual GLP-1/GLP agonist compound VK2735 for the ...
VKTX Stock 12 Months Forecast. $34.00. (187.40% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Viking Therapeutics in the last 3 months. The average price target is $34.00 with a high forecast of $40.00 and a low forecast of $28.00. The average price target represents a 187.40% change from the last price of $11.83.
Trending Stocks AMZN Amazon.com, Inc. Common Stock $105.11 -0.34 0.32% TSLA Tesla, Inc. Common Stock $164.04 -0.27 0.16% FRC FIRST REPUBLIC …VFS. VinFast Auto Ltd. Ordinary Shares. $17.15 -0.84 -4.67%. Find the latest news headlines from Viking Therapeutics, Inc. Common Stock (VKTX) at Nasdaq.com.The latest price target for . Viking Therapeutics (NASDAQ: VKTX) was reported by Truist Securities on Monday, October 2, 2023.The analyst firm set a price target for 32.00 expecting VKTX to rise ...Turning to the calls side of the option chain, the call contract at the $18.00 strike price has a current bid of $1.05. If an investor was to purchase shares of VKTX stock at the current price ...Tower Research Capital LLC TRC has reported a significant increase in its holdings of Viking Therapeutics, Inc. (NASDAQ:VKTX) during the first quarter of this year. According to the company’s recent disclosure with the Securities and Exchange Commission, TRC raised its holdings by 262.2%, acquiring an additional 9,391 shares …Viking Therapeutics. Market Cap. $1B. Today's Change. (1.85%) $0.21. Current Price. $11.56. Price as of November 22, 2023, 4:00 p.m. ET. You’re reading a free article with opinions that may ...Viking Therapeutics Earnings & Revenue FAQ. What were VKTX's earnings last quarter? On Oct 25, 2023, Viking Therapeutics (NASDAQ: VKTX) reported Q3 2023 ...Find the latest Earnings Report Date for Viking Therapeutics, Inc. Common Stock (VKTX) at Nasdaq.com. 06 Jan, 2021, 16:05 ET. SAN DIEGO, Jan. 6, 2021 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX ), a clinical-stage biopharmaceutical company focused on the development of novel ...Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company’s lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb …Since the year began, shares of Viking Therapeutics (NASDAQ:VKTX) exploded from about $8 to about $25 a share. All thanks to its potential treatment for obesity, VK2735.
Principal Financial Group Inc. bought a new stake in Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) during the second quarter, according to the company in its most recent Form 13F filing ...Nov 13, 2023 · SAN DIEGO, Nov. 13, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic ... Consolidated Research: 2019 Summary Expectations for Ctrip.com International, Anadarko Petroleum, Viking Therapeutics, Bruker, Tech Data, and Sierra Wireless — Fundamental Analysis, Key ...Instagram:https://instagram. nvidia stock upgradefinancial advisor wichita ksbank of america bondsmagnis energy technologies stock Viking Therapeutics, Inc. Common Stock (VKTX) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. Principal Financial Group Inc. bought a new stake in Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) during the second quarter, according to the company in its most recent Form 13F filing ... mortgage interest rates today mnwho offers stand alone gap insurance Apr 16, 2023 · VIKING THERAPEUTICS INC ( VKTX) is a small-cap value stock in the Biotechnology & Drugs industry. The rating using this strategy is 94% based on the firm’s underlying fundamentals and the stock ... spy predictions Mar 30, 2023 · Shares of Viking Therapeutics ( VKTX 6.23%) were up 89.7% for the week as of Thursday afternoon, after being up as much as 95.5% for the week, according to data provided by S&P Global Market ... Wirestock/iStock via Getty Images. Introduction. Viking Therapeutics (NASDAQ:VKTX) is a clinical-stage biotech firm working on treatments for metabolic and endocrine issues.Their main drug, VK2809 ...Viking Therapeutics, Inc. (VKTX) has been on a downward spiral lately with significant selling pressure. After declining 24.8% over the past four weeks, the stock looks well positioned for a trend ...